SPP1 and obesity disorder: Osteopontin (OPN) is a phosphorylated integrin-binding glycoprotein known to exert an atypical immune regulatory function on chronic inflammatory diseases such as cirrhosis, fibrosis, neuroinflammatory diseases, atherosclerosis, autoimmune diseases, obesity, diabetes, and cancer, among others.